Intellectual Property India Publishes Patent Application for 'Use Of (-)-Epigallocatechin Gallate Compound' Filed by Cf Pharmtech, Inc.; Ruijin Hospital, Shanghai Jiaotong University School Of Medicine; and Cf Pharmtech Guangzhou Limited

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517047414 A) filed by Cf Pharmtech, Inc.; Ruijin Hospital, Shanghai Jiaotong University School Of Medicine; and Cf Pharmtech Guangzhou Limited, Jiangsu, China, on May 16, for 'use of (-)-epigallocatechin gallate compound.'

Inventor(s) include Qu, Jieming; Zhao, Jingya; Xu, Lin; Che, Lin; Li, Xiujuan; Quan, Mengxue; and Liang, Bill Wenqing.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to the field of chemical pharmaceuticals and provides use of an (-)-epigallocatechin gallate (EGCG) compound. The present inventio...